Alpha-1 Antitrypsin Drugs Market Report

Global and China Alpha-1 Antitrypsin Drugs Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 30, 2022
  • PAGES：163
  • REPORT CODE：GMM1422629
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Alpha-1 Antitrypsin Drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Applied Genetic Technologies Corp

    • Abeona Therapeutics

    • Alnylam Pharmaceuticals

    • Baxter

    • Arrowhead Research Corporation

    • CSL Behring

    • Grifols

    • Baxalta

    • Kamada

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Parenteral

    • Inhalation

    Application:

    • Drugstore

    • Hospital

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Alpha-1 Antitrypsin Drugs Industry Overview

      • 1.1.1 Alpha-1 Antitrypsin Drugs Market Scope and Market Segments

      • 1.1.2 Alpha-1 Antitrypsin Drugs Industry Characteristics

      • 1.1.3 Global and China Alpha-1 Antitrypsin Drugs Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Alpha-1 Antitrypsin Drugs Production Value and Growth Rate (2017-2028)

    • 1.2 Global Alpha-1 Antitrypsin Drugs Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Parenteral

      • 1.2.2 Inhalation

    • 1.3 Global Alpha-1 Antitrypsin Drugs Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Drugstore

      • 1.3.2 Hospital

      • 1.3.3 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Alpha-1 Antitrypsin Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Alpha-1 Antitrypsin Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Alpha-1 Antitrypsin Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Alpha-1 Antitrypsin Drugs Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Alpha-1 Antitrypsin Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Alpha-1 Antitrypsin Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Alpha-1 Antitrypsin Drugs Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Alpha-1 Antitrypsin Drugs Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Alpha-1 Antitrypsin Drugs Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Alpha-1 Antitrypsin Drugs Industry Porter's Five Forces Model Analysis

      • 2.2.3 Alpha-1 Antitrypsin Drugs Industry PEST Analysis

    • 2.3 Alpha-1 Antitrypsin Drugs Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Alpha-1 Antitrypsin Drugs Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Alpha-1 Antitrypsin Drugs Industry

    Chapter 3 Global and China Alpha-1 Antitrypsin Drugs Market, by Manufacturer

    • 3.1 Global and China Alpha-1 Antitrypsin Drugs Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Alpha-1 Antitrypsin Drugs Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Alpha-1 Antitrypsin Drugs Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Alpha-1 Antitrypsin Drugs Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Alpha-1 Antitrypsin Drugs Market Top 3 Players

    Chapter 4 Global and China Alpha-1 Antitrypsin Drugs Market, by Type (2017-2028)

    • 4.1 Alpha-1 Antitrypsin Drugs Market Trend, by Type

    • 4.2 Global Alpha-1 Antitrypsin Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Alpha-1 Antitrypsin Drugs Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Alpha-1 Antitrypsin Drugs Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Alpha-1 Antitrypsin Drugs Price Trend, by Type (2017-2028)

    • 4.3 China Alpha-1 Antitrypsin Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Alpha-1 Antitrypsin Drugs Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Alpha-1 Antitrypsin Drugs Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Alpha-1 Antitrypsin Drugs Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Alpha-1 Antitrypsin Drugs Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Alpha-1 Antitrypsin Drugs Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Alpha-1 Antitrypsin Drugs Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Alpha-1 Antitrypsin Drugs Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Alpha-1 Antitrypsin Drugs Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Alpha-1 Antitrypsin Drugs Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Alpha-1 Antitrypsin Drugs Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Alpha-1 Antitrypsin Drugs Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Alpha-1 Antitrypsin Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Alpha-1 Antitrypsin Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Alpha-1 Antitrypsin Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Alpha-1 Antitrypsin Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Alpha-1 Antitrypsin Drugs Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Alpha-1 Antitrypsin Drugs Market Analysis

    • 7.1 North America Alpha-1 Antitrypsin Drugs Market, by Type

    • 7.2 North America Alpha-1 Antitrypsin Drugs Market, by Application

    • 7.3 North America Alpha-1 Antitrypsin Drugs Market Analysis and Forecast, by Country

      • 7.3.1 United States Alpha-1 Antitrypsin Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Alpha-1 Antitrypsin Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Alpha-1 Antitrypsin Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Alpha-1 Antitrypsin Drugs Market Analysis

    • 8.1 Europe Alpha-1 Antitrypsin Drugs Market, by Type

    • 8.2 Europe Alpha-1 Antitrypsin Drugs Market, by Application

    • 8.3 Europe Alpha-1 Antitrypsin Drugs Market Analysis and Forecast, by Country

      • 8.3.1 Germany Alpha-1 Antitrypsin Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Alpha-1 Antitrypsin Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Alpha-1 Antitrypsin Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Alpha-1 Antitrypsin Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Alpha-1 Antitrypsin Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Alpha-1 Antitrypsin Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Alpha-1 Antitrypsin Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Alpha-1 Antitrypsin Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Alpha-1 Antitrypsin Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Alpha-1 Antitrypsin Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Alpha-1 Antitrypsin Drugs Market Analysis

    • 9.1 APAC Alpha-1 Antitrypsin Drugs Market, by Type

    • 9.2 APAC Alpha-1 Antitrypsin Drugs Market, by Application

    • 9.3 APAC Alpha-1 Antitrypsin Drugs Market Analysis and Forecast, by Country

      • 9.3.1 China Alpha-1 Antitrypsin Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Alpha-1 Antitrypsin Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Alpha-1 Antitrypsin Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Alpha-1 Antitrypsin Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Alpha-1 Antitrypsin Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Alpha-1 Antitrypsin Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Alpha-1 Antitrypsin Drugs Market Analysis

    • 10.1 Latin America, Middle East and Africa Alpha-1 Antitrypsin Drugs Market, by Type

    • 10.2 Latin America, Middle East and Africa Alpha-1 Antitrypsin Drugs Market, by Application

    • 10.3 Latin America, Middle East and Africa Alpha-1 Antitrypsin Drugs Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Alpha-1 Antitrypsin Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Alpha-1 Antitrypsin Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Alpha-1 Antitrypsin Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Alpha-1 Antitrypsin Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Alpha-1 Antitrypsin Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Alpha-1 Antitrypsin Drugs Company Profiles

      • 11.1 Applied Genetic Technologies Corp

        • 11.1.1 Applied Genetic Technologies Corp Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Product Profiles, Application and Specification

        • 11.1.3 Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Abeona Therapeutics

        • 11.2.1 Abeona Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Abeona Therapeutics Alpha-1 Antitrypsin Drugs Product Profiles, Application and Specification

        • 11.2.3 Abeona Therapeutics Alpha-1 Antitrypsin Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Alnylam Pharmaceuticals

        • 11.3.1 Alnylam Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Product Profiles, Application and Specification

        • 11.3.3 Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Baxter

        • 11.4.1 Baxter Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Baxter Alpha-1 Antitrypsin Drugs Product Profiles, Application and Specification

        • 11.4.3 Baxter Alpha-1 Antitrypsin Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Arrowhead Research Corporation

        • 11.5.1 Arrowhead Research Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Product Profiles, Application and Specification

        • 11.5.3 Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 CSL Behring

        • 11.6.1 CSL Behring Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 CSL Behring Alpha-1 Antitrypsin Drugs Product Profiles, Application and Specification

        • 11.6.3 CSL Behring Alpha-1 Antitrypsin Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Grifols

        • 11.7.1 Grifols Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Grifols Alpha-1 Antitrypsin Drugs Product Profiles, Application and Specification

        • 11.7.3 Grifols Alpha-1 Antitrypsin Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Baxalta

        • 11.8.1 Baxalta Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Baxalta Alpha-1 Antitrypsin Drugs Product Profiles, Application and Specification

        • 11.8.3 Baxalta Alpha-1 Antitrypsin Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Kamada

        • 11.9.1 Kamada Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Kamada Alpha-1 Antitrypsin Drugs Product Profiles, Application and Specification

        • 11.9.3 Kamada Alpha-1 Antitrypsin Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Alpha-1 Antitrypsin Drugs Industry Investment Prospect and Risk Assessment

    • 12.1 Alpha-1 Antitrypsin Drugs Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Alpha-1 Antitrypsin Drugs Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Alpha-1 Antitrypsin Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure China Alpha-1 Antitrypsin Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Global Alpha-1 Antitrypsin Drugs Production Value and Growth Rate (2017-2028)

    • Figure China Alpha-1 Antitrypsin Drugs Production Value and Growth Rate (2017-2028)

    • Figure Global Alpha-1 Antitrypsin Drugs Market Size and Growth Rate of Parenteral (2017-2028)

    • Figure Global Alpha-1 Antitrypsin Drugs Market Size and Growth Rate of Inhalation (2017-2028)

    • Figure Global Alpha-1 Antitrypsin Drugs Market Size and Growth Rate of Drugstore (2017-2028)

    • Figure Global Alpha-1 Antitrypsin Drugs Market Size and Growth Rate of Hospital (2017-2028)

    • Figure Global Alpha-1 Antitrypsin Drugs Market Size and Growth Rate of Others (2017-2028)

    • Figure North America Alpha-1 Antitrypsin Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Alpha-1 Antitrypsin Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Alpha-1 Antitrypsin Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Alpha-1 Antitrypsin Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Alpha-1 Antitrypsin Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Alpha-1 Antitrypsin Drugs Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Alpha-1 Antitrypsin Drugs Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Alpha-1 Antitrypsin Drugs Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Alpha-1 Antitrypsin Drugs Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Alpha-1 Antitrypsin Drugs Market Share, by Manufacturer in 2021

    • Figure Global and China Alpha-1 Antitrypsin Drugs Market Share, by Manufacturer in 2022

    • Table Global Alpha-1 Antitrypsin Drugs Sales Volume, by Type (2017-2028)

    • Table Global Alpha-1 Antitrypsin Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Global Alpha-1 Antitrypsin Drugs Sales Volume Share, by Type (2017-2028)

    • Table Global Alpha-1 Antitrypsin Drugs Sales Value, by Type (2017-2028)

    • Table Global Alpha-1 Antitrypsin Drugs Sales Value Share, by Type (2017-2028)

    • Figure Global Alpha-1 Antitrypsin Drugs Price Trend, by Type (2017-2028)

    • Table China Alpha-1 Antitrypsin Drugs Sales Volume, by Type (2017-2028)

    • Table China Alpha-1 Antitrypsin Drugs Sales Volume Share, by Type (2017-2028)

    • Figure China Alpha-1 Antitrypsin Drugs Sales Volume Share, by Type (2017-2028)

    • Table China Alpha-1 Antitrypsin Drugs Sales Value, by Type (2017-2028)

    • Table China Alpha-1 Antitrypsin Drugs Sales Value Share, by Type (2017-2028)

    • Figure China Alpha-1 Antitrypsin Drugs Price Trend, by Type (2017-2028)

    • Table Global Alpha-1 Antitrypsin Drugs Sales Volume, by Application (2017-2028)

    • Table Global Alpha-1 Antitrypsin Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Global Alpha-1 Antitrypsin Drugs Sales Volume Share, by Application (2017-2028)

    • Table Global Alpha-1 Antitrypsin Drugs Sales Value, by Application (2017-2028)

    • Table Global Alpha-1 Antitrypsin Drugs Sales Value Share, by Application (2017-2028)

    • Figure Global Alpha-1 Antitrypsin Drugs Sales Value Share, by Application (2017-2028)

    • Table China Alpha-1 Antitrypsin Drugs Sales Volume, by Application (2017-2028)

    • Table China Alpha-1 Antitrypsin Drugs Sales Volume Share, by Application (2017-2028)

    • Figure China Alpha-1 Antitrypsin Drugs Sales Volume Share, by Application (2017-2028)

    • Table China Alpha-1 Antitrypsin Drugs Sales Value, by Application (2017-2028)

    • Table China Alpha-1 Antitrypsin Drugs Sales Value Share, by Application (2017-2028)

    • Figure China Alpha-1 Antitrypsin Drugs Sales Value Share, by Application (2017-2028)

    • Figure China Alpha-1 Antitrypsin Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure North America Alpha-1 Antitrypsin Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Alpha-1 Antitrypsin Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Alpha-1 Antitrypsin Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Alpha-1 Antitrypsin Drugs Production, Import, Consumption and Export (2017-2022)

    • Table North America Alpha-1 Antitrypsin Drugs Sales Volume, by Type (2017-2028)

    • Table North America Alpha-1 Antitrypsin Drugs Sales Volume Share, by Type (2017-2028)

    • Figure North America Alpha-1 Antitrypsin Drugs Sales Volume Share, by Type (2017-2028)

    • Table North America Alpha-1 Antitrypsin Drugs Sales Volume, by Application (2017-2028)

    • Table North America Alpha-1 Antitrypsin Drugs Sales Volume Share, by Application (2017-2028)

    • Figure North America Alpha-1 Antitrypsin Drugs Sales Volume Share, by Application (2017-2028)

    • Figure United States Alpha-1 Antitrypsin Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure United States Alpha-1 Antitrypsin Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Canada Alpha-1 Antitrypsin Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Alpha-1 Antitrypsin Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Alpha-1 Antitrypsin Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Alpha-1 Antitrypsin Drugs Sales Value and Growth Rate (2017-2028)

    • Table Europe Alpha-1 Antitrypsin Drugs Sales Volume, by Type (2017-2028)

    • Table Europe Alpha-1 Antitrypsin Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Europe Alpha-1 Antitrypsin Drugs Sales Volume Share, by Type (2017-2028)

    • Table Europe Alpha-1 Antitrypsin Drugs Sales Volume, by Application (2017-2028)

    • Table Europe Alpha-1 Antitrypsin Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Europe Alpha-1 Antitrypsin Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Germany Alpha-1 Antitrypsin Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Alpha-1 Antitrypsin Drugs Sales Value and Growth Rate (2017-2028)

    • Figure UK Alpha-1 Antitrypsin Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure UK Alpha-1 Antitrypsin Drugs Sales Value and Growth Rate (2017-2028)

    • Figure France Alpha-1 Antitrypsin Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure France Alpha-1 Antitrypsin Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Italy Alpha-1 Antitrypsin Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Alpha-1 Antitrypsin Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Alpha-1 Antitrypsin Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Alpha-1 Antitrypsin Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Spain Alpha-1 Antitrypsin Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Alpha-1 Antitrypsin Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Alpha-1 Antitrypsin Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Alpha-1 Antitrypsin Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Poland Alpha-1 Antitrypsin Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Alpha-1 Antitrypsin Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Russia Alpha-1 Antitrypsin Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Alpha-1 Antitrypsin Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Alpha-1 Antitrypsin Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Alpha-1 Antitrypsin Drugs Sales Value and Growth Rate (2017-2028)

    • Table APAC Alpha-1 Antitrypsin Drugs Sales Volume, by Type (2017-2028)

    • Table APAC Alpha-1 Antitrypsin Drugs Sales Volume Share, by Type (2017-2028)

    • Figure APAC Alpha-1 Antitrypsin Drugs Sales Volume Share, by Type (2017-2028)

    • Table APAC Alpha-1 Antitrypsin Drugs Sales Volume, by Application (2017-2028)

    • Table APAC Alpha-1 Antitrypsin Drugs Sales Volume Share, by Application (2017-2028)

    • Figure APAC Alpha-1 Antitrypsin Drugs Sales Volume Share, by Application (2017-2028)

    • Figure China Alpha-1 Antitrypsin Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure China Alpha-1 Antitrypsin Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Japan Alpha-1 Antitrypsin Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Alpha-1 Antitrypsin Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Alpha-1 Antitrypsin Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Alpha-1 Antitrypsin Drugs Sales Value and Growth Rate (2017-2028)

    • Figure India Alpha-1 Antitrypsin Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure India Alpha-1 Antitrypsin Drugs Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Alpha-1 Antitrypsin Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Alpha-1 Antitrypsin Drugs Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Alpha-1 Antitrypsin Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Alpha-1 Antitrypsin Drugs Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Alpha-1 Antitrypsin Drugs Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Alpha-1 Antitrypsin Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Alpha-1 Antitrypsin Drugs Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Alpha-1 Antitrypsin Drugs Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Alpha-1 Antitrypsin Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Alpha-1 Antitrypsin Drugs Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Alpha-1 Antitrypsin Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Alpha-1 Antitrypsin Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Alpha-1 Antitrypsin Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Alpha-1 Antitrypsin Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Alpha-1 Antitrypsin Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Alpha-1 Antitrypsin Drugs Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Alpha-1 Antitrypsin Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Alpha-1 Antitrypsin Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Alpha-1 Antitrypsin Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Alpha-1 Antitrypsin Drugs Sales Value and Growth Rate (2017-2028)

    • Table Applied Genetic Technologies Corp Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Applied Genetic Technologies Corp Product Profiles, Application and Specification

    • Table Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Abeona Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Abeona Therapeutics Product Profiles, Application and Specification

    • Table Abeona Therapeutics Alpha-1 Antitrypsin Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Alnylam Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Alnylam Pharmaceuticals Product Profiles, Application and Specification

    • Table Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Baxter Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Baxter Product Profiles, Application and Specification

    • Table Baxter Alpha-1 Antitrypsin Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Arrowhead Research Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Arrowhead Research Corporation Product Profiles, Application and Specification

    • Table Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table CSL Behring Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table CSL Behring Product Profiles, Application and Specification

    • Table CSL Behring Alpha-1 Antitrypsin Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Grifols Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Grifols Product Profiles, Application and Specification

    • Table Grifols Alpha-1 Antitrypsin Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Baxalta Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Baxalta Product Profiles, Application and Specification

    • Table Baxalta Alpha-1 Antitrypsin Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Kamada Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Kamada Product Profiles, Application and Specification

    • Table Kamada Alpha-1 Antitrypsin Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US